Correction to: Scientific Reports https://doi.org/10.1038/s41598-022-21175-7, published online 09 November 2022
Kim Francis Andersen was inadvertently omitted from the author list in the original version of this Article.
The Author Contributions section now reads:
“L.M.R. and A.K. conceived the study and design. L.M. included the patients and drafted the manuscript; T.B. performed the experiments; M.F., K.F.A., A.L., J.F. and A.K. supported the data analysis and critically revised the manuscript. All authors read and approved the final manuscript.”
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Risør, L.M., Binderup, T., Fosbøl, M.Ø. et al. Author Correction: Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients. Sci Rep 13, 1346 (2023). https://doi.org/10.1038/s41598-023-28618-9
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-023-28618-9
